Skip to main content

Table 7 Relation between FSFI; QOL and genital wart characteristics

From: Sexual dysfunction in women with genital warts: a cross-sectional study

 

FSFI

P value

QOL

P value

No. of GW

 Single

21.6 ± 2.83

* < 0.001

7.89 ± 2.91

* < 0.001

 Multiple

14.97 ± 6.92

10.82 ± 3.63

Recurrence of GW

 Yes

13.1 ± 5.13

* < 0.001

10.78 ± 2.96

* 0.005

 No

20.01 ± 4.82

8.84 ± 3.59

Husband infection with GWs

 Yes

17.2 ± 6.31

0.84

10.7 ± 3.5

0.71

 No

17.5 ± 6.12

10.4 ± 2.9

Condom use

 Yes

18.7 ± 7.3

0.056

8.78 ± 2.1

0.29

 No

15.6 ± 5.9

9.75 ± 3.8

Treatment type

 Cryotherapy

16.5 ± 6.3

0.72

10.2 ± 3.25

0.11

 Podophyllin solution

16.6 ± 6.7

8.3 ± 3.3

 Candida antigen

19.1 ± 3.4

8.03 ± 2.6

  1. SD standard deviation; QOL quality of life; HPV Human papillomavirus; FSFI Female Sexual Function Index; GW Genital wart
  2. *Significant, P value < 0.05 is statistically significant, p < 0.001 is highly significant